Key Account Manager R & I – Constanta AstraZeneca is a global, science-led, patient-focused biopharmaceutical company...’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. In Respiratory & Immunology Therapy Area...
documents processed according to the objectives set by the direct manager; Processing transactions for different clients... ( B2-C1); Experience in the HR field, Customer Service, or any other area; Good Client handling skills; Problem-solving...
Key Account Manager R & I – Bacau AstraZeneca is a global, science-led, patient-focused biopharmaceutical company...’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. In Respiratory & Immunology Therapy Area...
Key Account Manager R & I – Bucuresti AstraZeneca is a global, science-led, patient-focused biopharmaceutical company...’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. In Respiratory & Immunology Therapy Area...
among relevant HCPs; . Area to cover is BH, MM, SM counties ; · Work with Field Force Manager / Franchise Lead to develop...Key Account Manager R & I – Oradea / Baia Mare AstraZeneca is a global, science-led, patient-focused...
Key Account Manager R & I – Iasi AstraZeneca is a global, science-led, patient-focused biopharmaceutical company...’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. In Respiratory & Immunology Therapy Area...
the regional Areas Services Manager with the build, the analysis and the consolidation of financial reports. Additional.../guidance, provide general assistance to Services Department. OPPORTUNITIES You will work closely with the Regional Area...
Key Account Manager R & I – Timisoara AstraZeneca is a global, science-led, patient-focused biopharmaceutical company...’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. In Respiratory & Immunology Therapy Area...
Intocmirea ofertelor si a solutiilor tehnice; urmarirea ofertelor pana la negocierea contractelor si incheierea vanzarii Mentinerea contractelor cu clientii traditionali ai firmei. Crearea si dezvoltarea unui portofoliu propriu de client...
Key Account Manager R & I – Craiova AstraZeneca is a global, science-led, patient-focused biopharmaceutical company...’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. In Respiratory & Immunology Therapy Area...
As the year 2024 is nearing its end, investors will be hoping for Santa Claus rally. This phenomenon occurs when stocks rise on the last five trading sessions of December and the first two trading sessions of January Continue Reading »
Transrail Lighting IPO: The public issue is poised to witness its final day of public bidding on Monday, December 23. The IPO has been subscribed 5.31x the shares available as of Day 2. Check details on whether to apply or not? Continue Reading »
What do you think was the top performing asset of 2024? Some microcap stock? Bitcoin? Real estate? It was actually Diljit Dosanjh’s pan-India concert tickets. This analysis will surprise you. Continue Reading »
Senores Pharma IPO Apply or not: The Senores Pharmaceuticals' public issue will close for public bidding on December 24. The IPO has received 1.78x subscription on Day 1, as of last week Friday. Continue Reading »
Unimech Aerospace IPO price band is set at ₹745 to ₹785 per share and the IPO lot size is 19 shares. The company plans to raise ₹500 crore at the upper-end of the price band of the book built issue which is a combination of fresh issue and OFS worth ₹250 crore each. Continue Reading »
DAM Capital Advisors IPO price band is set at ₹269 to ₹283 per share. The ₹840.25-crore worth DAM Capital Advisors IPO is entirely an offer for sale (OFS) of 2.97 crore shares. Continue Reading »
Mamata Machinery IPO price band was set at ₹230 to ₹243 per share. The company aims to raise ₹179.39 crore from the book-built issue which is entirely an offer for sale of 73.82 lakh shares. Continue Reading »